You are using an outdated browser. Please
upgrade your browser to improve your experience.
The Globostad study OBS15990 eDiary App has been developed for the Prospective Observational Study of adult patients receiving Dupixent for atopic dermatitis
GLOBOSTAD
by Exco InTouch
What is it about?
The Globostad study OBS15990 eDiary App has been developed for the Prospective Observational Study of adult patients receiving Dupixent for atopic dermatitis.
App Store Description
The Globostad study OBS15990 eDiary App has been developed for the Prospective Observational Study of adult patients receiving Dupixent for atopic dermatitis.
The App will collect eDiary information for subjects registered into this study.
*Note: this App requires an activation code and can only be accessed by subjects who are participating in the OBS15990 trial.
Disclaimer:
AppAdvice does not own this application and only provides images and links contained in the iTunes Search API, to help our users find the best apps to download. If you are the developer of this app and would like your information removed, please send a request to takedown@appadvice.com and your information will be removed.
AppAdvice does not own this application and only provides images and links contained in the iTunes Search API, to help our users find the best apps to download. If you are the developer of this app and would like your information removed, please send a request to takedown@appadvice.com and your information will be removed.
